Robert Shawah | executive |
David Luci | executive |
Robert DeLuccia | executive |
Michael Okunewitch | analyst |
Wing Yip | analyst |
James Molloy | analyst |
Ladies and chairman, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Rob Shawah, Chief Financial Officer. Please go ahead.
Thank you, Ryan.